AAAAAA
Results: 1-25/71
Authors:
UROWITZ MB
GLADMAN DD
Citation: Mb. Urowitz et Dd. Gladman, MEASURES OF DISEASE-ACTIVITY AND DAMAGE IN SLE, Bailliere's clinical rheumatology, 12(3), 1998, pp. 405-413
Authors:
BRUCE IN
GLADMAN DD
UROWITZ MB
Citation: In. Bruce et al., DETECTION AND MODIFICATION OF RISK-FACTORS FOR CORONARY-ARTERY DISEASE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - A QUALITY IMPROVEMENT STUDY, Clinical and experimental rheumatology, 16(4), 1998, pp. 435-440
Authors:
RAHMAN P
GLADMAN DD
UROWITZ MB
Citation: P. Rahman et al., SMOKING INTERFERES WITH EFFICACY OF ANTIMALARIAL THERAPY IN CUTANEOUSLUPUS, Journal of rheumatology, 25(9), 1998, pp. 1716-1719
Authors:
RAHMAN P
GLADMAN DD
UROWITZ MB
Citation: P. Rahman et al., CLINICAL PREDICTORS OF FETAL-OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of rheumatology, 25(8), 1998, pp. 1526-1530
Authors:
WANG B
GLADMAN DD
UROWITZ MB
Citation: B. Wang et al., FATIGUE IN LUPUS IS NOT CORRELATED WITH DISEASE-ACTIVITY, Journal of rheumatology, 25(5), 1998, pp. 892-895
Authors:
RAHMAN P
HUMPHREYMURTO S
GLADMAN DD
UROWITZ MB
Citation: P. Rahman et al., EFFICACY AND TOLERABILITY OF METHOTREXATE IN ANTIMALARIAL RESISTANT LUPUS ARTHRITIS, Journal of rheumatology, 25(2), 1998, pp. 243-246
Authors:
CHAUDHRYAHLAWALIA V
GLADMAN DD
UROWITZ MB
BOGOCH E
FAREWELL VT
Citation: V. Chaudhryahlawalia et al., RADIOGRAPHIC REPORTS IN OSTEONECROSIS OF THE HIP IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Clinical orthopaedics and related research, (352), 1998, pp. 131-136
Authors:
BRUCE IN
GLADMAN DD
UROWITZ MB
HALLETT DC
Citation: In. Bruce et al., THE NATURAL-HISTORY OF HYPERCHOLESTEROLEMIA IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 636-636
Authors:
RAHMAN P
UROWITZ MB
GLADMAN DD
BRUCE IN
GENEST J
Citation: P. Rahman et al., CONTRIBUTION OF TRADITIONAL RISK-FACTORS TO CORONARY-ARTERY DISEASE (CAD) IN PATIENTS WITH SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1118-1118
Authors:
KAGAL A
GLADMAN DD
UROWITZ MB
Citation: A. Kagal et al., DESCRIBING DISEASE-ACTIVITY IN SLE OVER TIME, Arthritis and rheumatism, 41(9), 1998, pp. 1124-1124
Authors:
BRUCE IN
GLADMAN DD
UROWITZ MB
Citation: In. Bruce et al., PROLONGED TREATMENT FREE PERIODS IN A COHORT WITH SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1125-1125
Authors:
BAJAJ S
ALBERT L
GLADMAN DD
UROWITZ MB
HALLETT D
Citation: S. Bajaj et al., THE CLINICAL UTILITY OF SERIAL RENAL BIOPSIES IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1487-1487
Authors:
RAHMAN P
GLADMAN DD
UROWITZ MB
Citation: P. Rahman et al., SIGNIFICANCE OF ISOLATED HEMATURIA IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1494-1494
Authors:
RAHMAN P
GLADMAN DD
UROWITZ MB
Citation: P. Rahman et al., SIGNIFICANCE OF ISOLATED PYURIA IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1495-1495
Authors:
BRUCE IN
ORLACCHIO A
GLADMAN DD
UROWITZ MB
SONG YQ
STGEORGEHYSLOP P
Citation: In. Bruce et al., NO ASSOCIATION BETWEEN APOLIPOPROTEIN-E GENOTYPE AND CORONARY-ARTERY DISEASE (CAD) OR COGNITIVE DYSFUNCTION IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1518-1518
Authors:
BRUCE IN
GLADMAN DD
UROWITZ MB
Citation: In. Bruce et al., PATIENT NONADHERENCE - AN IMPORTANT FACTOR CONTRIBUTING TO CHRONIC RENAL-INSUFFICIENCY (CRI) IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1800-1800
Authors:
BRUCE IN
CLARKSOLONINKA CA
SPITZER KA
GLADMAN DD
UROWITZ MB
LASKIN CA
Citation: In. Bruce et al., ANTIBODIES TO BETA-2-GLYCOPROTEIN-1 IN PATIENTS WITH SLE DO NOT DISCRIMINATE THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS), Arthritis and rheumatism, 41(9), 1998, pp. 1801-1801
Authors:
BRUCE IN
FRASER K
GLADMAN DD
UROWITZ MB
MOLDOFSKY H
Citation: In. Bruce et al., SLEEP ABNORMALITIES IN PATIENTS WITH SLE AND FATIGUE, Arthritis and rheumatism, 41(9), 1998, pp. 1802-1802
Authors:
GLANZ BI
SLONIM D
UROWITZ MB
GLADMAN DD
GOUGH J
MACKINNON A
Citation: Bi. Glanz et al., PATTERN OF NEUROPSYCHOLOGIC DYSFUNCTION IN INACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS, Neuropsychiatry, neuropsychology, and behavioral neurology, 10(4), 1997, pp. 232-238
Authors:
UROWITZ MB
GLADMAN DD
ABUSHAKRA M
FAREWELL VT
Citation: Mb. Urowitz et al., MORTALITY STUDIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RESULTS FROM A SINGLE-CENTER .3. IMPROVED SURVIVAL OVER 24 YEARS, Journal of rheumatology, 24(6), 1997, pp. 1061-1065
Authors:
GLADMAN DD
UROWITZ MB
GOUGH J
MACKINNON A
Citation: Dd. Gladman et al., FIBROMYALGIA IS A MAJOR CONTRIBUTOR TO QUALITY-OF-LIFE IN LUPUS, Journal of rheumatology, 24(11), 1997, pp. 2145-2148
Authors:
KREIDSTEIN S
UROWITZ MB
GLADMAN DD
GOUGH J
Citation: S. Kreidstein et al., HORMONE REPLACEMENT THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of rheumatology, 24(11), 1997, pp. 2149-2152
Authors:
RAHMAN P
HUMPHREYMURTO S
GLADMAN DD
UROWITZ MB
Citation: P. Rahman et al., CYTOTOXIC THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - EXPERIENCE FROM ASINGLE-CENTER, Medicine, 76(6), 1997, pp. 432-437
Authors:
RAHMAN P
GLADMAN DD
UROWITZ MB
Citation: P. Rahman et al., EFFICACY OF ANTIMALARIAL THERAPY IN CUTANEOUS LUPUS IN SMOKERS VERSUSNONSMOKERS, Arthritis and rheumatism, 40(9), 1997, pp. 166-166
Authors:
MAK VC
BRUCE IN
GLADMAN DD
UROWITZ MB
Citation: Vc. Mak et al., FACTORS ASSOCIATED WITH FATIGUE IN SLE PATIENTS, Arthritis and rheumatism, 40(9), 1997, pp. 1065-1065